Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ketoprofen + cyclobenzaprine is a compounded pharmaceutical combination used primarily for topical pain relief. Ketoprofen is a non-steroidal anti-inflammatory drug (NSAID) that reduces inflammation and pain by inhibiting the body's production of prostaglandins, substances involved in pain, fever, and inflammation. Cyclobenzaprine is a skeletal muscle relaxant that acts centrally in the brainstem to reduce muscle spasms by inhibiting descending serotonergic pathways and decreasing activity of motor neurons. This combination is typically formulated as a topical gel or cream for localized treatment of conditions such as osteoarthritis, fibromyalgia, tendinitis, bursitis, muscle spasms, joint pain from arthritis (including rheumatoid arthritis), strains, sprains, and other musculoskeletal injuries[1][3][5][6]. The compounded formulation aims to provide both anti-inflammatory effects from ketoprofen and muscle relaxation from cyclobenzaprine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ketoprofen + cyclobenzaprine.